Procyrion
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3900 Essex Ln Ste 850, Houston, Texas, 7...Phone Number
(832) 536-1601Website
www.procyrion.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Procyrion
Procyrion is a medical technology company focused on developing innovative solutions for heart failure patients. Their flagship product, Aortix, is a catheter-deployed circulatory assist device designed to support patients who are too sick for medication alone. The device aims to reduce cardiac workload and improve renal perfusion, addressing the critical cardiorenal syndrome that affects many heart failure patients. Procyrion's team consists of experienced life science entrepreneurs, engineers, and cardiologists dedicated to meeting the unmet clinical needs in this area.Explore more
Procyrion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Procyrion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Procyrion has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Procyrion
Product Launch: Get notified when Procyrion launches new products
Click to see if Procyrion had a recent Job posting/layoffs
Earning: See what the market has to say on Procyrion recently announced quarterly report
Funding: Get notified immidiatlly once Procyrion has new funding data
Website visits: Recent activity has been detected on your website
Check out if Procyrion is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Procyrion, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Procyrion as Masked Content
Find 2 more new buyers
Compare Similar Companies to Procyrion
Compare insights from companies similar to Procyrion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Procyrion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Procyrion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Procyrion.
Procyrion financials insights
Gather financial insights about Procyrion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$650K
2015
Series B
$10M
2018
Series C
$16M
2024
Series E
$57.7M
Procyrion Tech Stack
A closer look at the technologies used by Procyrion
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
, a medical device technology company, recently secured $30 million in Series D funding.
Funding
Lateral Move
Executive Move
Executive Moves, Lateral Move, Personnel Moves, Left Company
Procyrion News & Media
Procyrion Announces Appointment of Lucas Buchanan to Board of Directors
Industry veteran brings expertise in commercialization, operations, business development and finance Company continues to focus on DRAIN-HF pivotal IDE trial and preparing for US commercialization of its percutaneous mechanical circulatory support (pMCS) technology HOUSTON, Sept. 9, 2024...Procyrion raises $57M to complete development of its percutaneous heart failure pump
Procyrion has assembled $57.7 million in proceeds to continue the pivotal trial of its miniaturized pumps to help maintain blood flow in patients suffering from severe heart failure. | The company’s series E round was led by Fannin Partners, alongside backing from previous investors such as Bluebird Ventures, and includes the conversion of $10 million in previous interim financing.Procyrion Closes $57.7 Million in Series E Financing
Funding to support the DRAIN-HF pivotal IDE trial evaluating the company's Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation HOUSTON, Feb. 5, 2024 /PRNewswire/ -- Procyrion™, Inc., a medical device company dedicated to improving outcomes...Procyrion Secures New Medicare Payment Codes Applicable to its Aortix™ Percutaneous Mechanical Circulatory Support Technology
New inpatient procedure codes map to same DRG payment as codes for commercially available pMCS devices Company has also received CMS approval for Medicare coverage during its US IDE pivotal trial HOUSTON, Sept. 7, 2023 /PRNewswire/ -- Procyrion, Inc., a medical device company dedicated to...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Procyrion
Sign Up For FreeTo access detailed company insights
Procyrion is a medical technology company focused on developing innovative solutions for heart failure patients. Their flagship product, Aortix, is a catheter-deployed circulatory assist device designed to support patients who are too sick for medication alone. The device aims to reduce cardiac workload and improve renal perfusion, addressing the c... Read More
